John A. Latham, Chief Scientific Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 40,000 shares at $30.05 ($1.2M) on 2016-05-27, disclosed to the SEC on 2016-06-01.
Scheduled sale ($1.2M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.05 | 6,401 | $192K | 16.0% |
| 2 | $30.04 | 33,599 | $1.0M | 84.0% |
| Total | $30.04 avg | 40,000 | $1.2M | 100% |
| Filing → |
| ALDR | SELL | 2018-09-06 | $450K | — | Filing → |
| ALDR | SELL | 2018-08-02 | $489K | — | Filing → |
| ALDR | SELL | 2018-07-03 | $387K | — | Filing → |